The Pulse of New York Tech
OncoPrecision is developing functional assays for data-driven, patient-specific cancer therapy selection. Founded in 2020, OncoPrecision is backed by investors that include GRID EXPONENTIAL
WRITE FOR US
NYC TECH EVENTS
NYC TECH NEWS
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.